← FDA Drug Approvals (Drugs@FDA)
DARIFENACIN
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: MACLEODS PHARMS LTD · Approved 2017-07-28
Drug application
- FDA Application #
ANDA207302- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- DARIFENACIN
- Generic name
- DARIFENACIN
- Active ingredients
- DARIFENACIN HYDROBROMIDE
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- MACLEODS PHARMS LTD
- Manufacturer
- Macleods Pharmaceuticals Limited
- First approval
- 2017-07-28
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown